ABSTRACT

INTRODUCTION Thrombin plays a pivotal role in platelet-mediated thrombosis associated with atheromatous plaque rupture in patients with acute coronary syndromes. Thrombin inhibition is, therefore, a basic therapeutic goal in this setting, together with thrombolysis and platelet inhibition.